Home / Share Price Target / Orchpharma
Orchid Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Orchid Pharma Limited | |||
 | Symbol: ORCHPHARMA | ||
| Price: ₹1,440.4 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Orchid Pharma Brief Company Overview
- 1.1: Orchid Pharma Limited: A Pharma Leader
- 1.2: Orchid Pharma Financial Performance
- 1.2.1: Is Orchid Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Orchid Pharma Share Price Target For 2024
- 2.1.1: Orchid Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Orchid Pharma Share Price Prediction For 2024
- 2.2: Orchid Pharma Share Price Target For 2025
- 2.2.1: Orchid Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Orchid Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Orchid Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Orchid Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Orchid Pharma Past Performance
Orchid Pharma Brief Company Overview
Orchid Pharma Limited: A Pharma Leader
Orchid Pharma Limited, established in 1992, is a renowned pharmaceutical company headquartered in Chennai, India. As a subsidiary of Dhanuka Laboratories Limited, Orchid Pharma engages in a comprehensive range of pharmaceutical activities.
Key Products and Services:- Development, manufacture, and marketing of active pharmaceutical ingredients (APIs)
- Bulk actives, finished dosage formulations, and nutraceuticals
- New drug discovery systems and pharmaceutical R&D services
- Anti-infectives
- Anti-inflammatory
- Central nervous system
- Cardiovascular segment
- Nutraceuticals
- Oral and sterile products
Advertisement
Orchid Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 6,513.09 Crore | Market valuation of Orchid Pharma's shares. |
| Revenue (TTM) | 880.85 Crore | Total revenue generated by Orchid Pharma over the past twelve months. |
| Net Income (TTM) | +112.11 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 9.83% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 12.72% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +33.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +212.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 11.55 | Company's total debt divided by total shareholder equity. |
| Total Debt | 135.18 Crore | Sum of Orchid Pharma's current & long-term financial obligations. |
| Total Cash | 3.61 Crore | Total amount of liquid funds available to Orchid Pharma. |
| Beta | 2.08 | Beta is greater than 1 indicating that the Orchid Pharma's price is more volatile than the market. |
Is Orchid Pharma A Good Buy For Long Term?
No valid response content found
To predict the Orchid Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Orchid Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Orchid Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Orchid Pharma shares in 2024, see the table below.
Advertisement
Orchid Pharma Share Price Target Table For 2024
| Orchid Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1468.80 (+1.97%) | Price Action: 01 Nov 2024 High |
| 2024 Target 2 | 1452.64 (+0.84%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 1436.05 (-0.31%) | Price Action: 12 Nov 2024 Low |
| Current Price | 1440.40 | Orchid Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1422.81 (-1.23%) | Price Action: Chart |
| Stop Loss 2 | 1405.82 (-2.41%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 3 | 1390.40 (-3.48%) | Fibonacci Retracement Extended 28.2% |
Summary: Orchid Pharma Share Price Prediction For 2024
In summary, Orchid Pharma has surged by ₹727.90, achieving a notable +102.16% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Orchid Pharma for 2024 predicts an additional rise of -0.31% to 1.97% by the end of 2024 with three potential targets T1: 1436.05, T2: 1452.64, T3: 1468.80. Stop Loss at SL1: 1422.81, SL2: 1405.82, SL3: 1390.40.
Orchid Pharma has a 52-week high of ₹1590.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹521.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Orchid Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Orchid Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Orchid Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Orchid Pharma shares in 2025, see the table below.
Advertisement
Orchid Pharma Share Price Target Table For 2025
| Orchid Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 2179.63 (+51.32%) | Price Action: Chart |
| 2025 Target 2 | 2138.99 (+48.49%) | Price Action: Chart |
| 2025 Target 1 | 2117.81 (+47.02%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1440.40 | Orchid Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 1264.18 (-12.24%) | Price Action: Dec 2018 High |
| Stop Loss 2 | 1239.05 (-13.98%) | Price Action: 28 Oct 2024 Low |
| Stop Loss 3 | 1226.20 (-14.88%) | Price Action: Mar 2024 High |
Summary: Orchid Pharma Share Price Prediction For 2025
In summary, Orchid Pharma has surged by ₹727.90, achieving a notable +102.16% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Orchid Pharma for 2025 predicts an additional rise of 47.02% to 51.32% by the end of 2025 with three potential targets T1: 2117.81, T2: 2138.99, T3: 2179.63. Stop Loss at SL1: 1264.18, SL2: 1239.05, SL3: 1226.20.
Orchid Pharma has a All-Time high of ₹2654.25, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹521.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Orchid Pharma, we have created a specific page for that check here: Orchid Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Orchid Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Orchid Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.33% over the next 15 years.
For complete year by year Orchid Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Orchid Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Orchid Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,440.4 | [Current Price] |
| 2024 | ₹1,636.39 | 13.6% |
| 2025 | ₹1,955.2 | 19.48% |
| 2026 | ₹2,020.62 | 3.34% |
| 2027 | ₹2,165.05 | 7.14% |
| 2028 | ₹2,328.05 | 7.52% |
| 2029 | ₹3,239.6 | 39.15% |
| 2030 | ₹3,556.9 | 9.79% |
| 2031 | ₹3,442.89 | -3.21% |
| 2032 | ₹3,500.93 | 1.68% |
| 2033 | ₹3,606.71 | 3.02% |
| 2034 | ₹4,842.81 | 34.27% |
| 2035 | ₹5,158.6 | 6.52% |
| 2036 | ₹4,865.16 | -5.69% |
| 2037 | ₹4,836.81 | -0.59% |
| 2038 | ₹4,885.35 | 1% |
| 2039 | ₹7,350.3 | 50.45% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Orchid Pharma Past Performance
- In 1995, Orchid Pharma opening price was ₹66.67
- As of Thu 14 Nov 2024 the price stands at ₹1,440.4.
- This represents a Compound Annual Growth Rate (CAGR) of 10.79%.
- In 29 years, an investment of 10,000 would have become ₹2.16 Lakh.
As we wrap up, we hope you like our study on Orchid Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Orchid Pharma Share Price History
- Orchid Pharma Price Target Tomorrow
- Orchid Pharma Dividend History
- Orchid Pharma Bonus History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
